The Journal of Neuroscience‘s retraction notices often give us plenty to chew on, and a new Expression of Concern does the same.
In the notice — for a 16-year-old paper — the journal notes three cases of what certainly sounds like image manipulation, but carefully avoids calling it that: Continue reading He said, she said: Journal of Neuroscience expresses concern, but doesn’t pursue investigation
Back in May we reported on an Expression of Concern in Cell Cycle — a notice that had entered life as a retraction but mysteriously metamorphosed into the less dramatic form. The statement limned a rather bizarre dispute between researchers who crossed paths at the University of Minnesota and are now embroiled in litigation over ownership of the data.
Now, it gets weirder. Responding to further correspondence from the university, the journal has effectively washed its hands of the matter — without bothering to wipe down the sink or hang up the towel.
Here’s the “Comment on Expression of Concern“: Continue reading Not our problem: Journal bows out of data dispute after U Minn challenges previous statement
It’s not quite the Lazlo Letters of behavioral science, but the Journal of Neuropsychiatry and Clinical Neurosciences has issued an expression of concern after discovering that it had been publishing letters that had been published in other journals.
Here’s how the notice describes the matter: Continue reading Letter writing campaign leads to expression of concern over duplication
Shigeaki Kato, an endocrinology researcher who resigned last year from the University of Tokyo and has retracted five papers, now has five more papers subject to an expression of concern.
Here’s the notice in Molecular and Cellular Biology: Continue reading Five Kato papers subject to an expression of concern, plus, a statute of limitations on correcting the literature?
The journal Cell Cycle is expressing a “note” of concern about a 2012 paper by a former researcher at the University of Minnesota, who has claimed that her mentor at the institution was violating her copyright. It turns out the journal had briefly retracted the paper, but reversed itself with the expression of concern — a curious about-face that, in our experience, often indicates the work of lawyers.
That seems to be the case here, too.
The article, “Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes,” was already the subject of an erratum, available here:
Continue reading Amid a legal dispute, journal downgrades a retraction to an expression of concern
The editor of Clinical Medicine Insights: Oncology has issued an Expression of Concern over a 2008 paper by a group of authors in China after identifying “flaws” in one of the figures.
The article, “Exvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cells derived from umbilical cord blood for immunotherapy treatment,” purported to show that:
tumor-specific antigens present on exosomes can be presented by DCs [dendritic cells] derived from unrelated umbilical cord blood to induce tumor specific cytotoxicity and this may represent as a novel immunotherapy for ovarian cancer.
But according to William C. S. Cho, editor of the journal, there’s reason to doubt the conclusions. As the notice explains:
Continue reading Dodgy figure in cord blood paper prompts Expression of Concern in oncology journal
The journal Neurology has issued an Expression of Concern over recommendations it published earlier this year regarding the treatment of multiple sclerosis.
The journal’s website received multiple comments from clinicians expressing their own concern about the flawed recommendation, which was published as part of a paper titled “The American Academy of Neurology’s Top Five Choosing Wisely recommendations.” The problematic item was number 4: Continue reading Journal expresses concern over flawed multiple sclerosis treatment guideline
Bharat Aggarwal, the MD Anderson researcher who has threatened to sue us while under investigation by his institution for alleged misconduct, now has two Expressions of Concern in addition to two corrections and two unexplained withdrawals.
Both of the papers were published in Blood. The Expression of Concern for “Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-κB signaling pathway,” reads: Continue reading Two Expressions of Concern in Blood for MD Anderson’s Aggarwal, who has threatened to sue Retraction Watch
A 2003 paper is now subject to an Expression of Concern after its author reused a lot of its material in a 2007 paper.
Here’s the Expression of Concern for “New therapeutic target in primary headaches – blocking the CGRP receptor” by Lars Edvinsson of the University of Copehagen: Continue reading Duplicate publication of headache paper earns Expression of Concern, erratum
BMC Genomics has issued an expression of concern for a 2011 paper by a prominent Argentine chemist, Ariel Fernandez, whose work covers several disciplines — “His research spans representation theory in algebra, physical chemistry, molecular biophysics, and more recently, molecular evolution and drug discovery” — and institutions. And therein lies the tale.
Fernandez appeared as the first author of the article, titled “Subfunctionalization reduces the fitness cost of gene duplication in humans by buffering dosage imbalances,” along with a pair of researchers from Taiwan. Fernandez’s affiliations were listed as being with the Instituto Argentino de Matemática “Alberto P. Calderón”, CONICET (National Research Council of Argentina), in Buenos Aires, the Department of Computer Science at the University of Chicago, and the Morgridge Institute for Research, in Madison, Wisc.
According to the abstract:
Continue reading “Conflicting investigations” prompt expression of concern in BMC Genomics